Consultation on the commercial release of a genetically modified (GM) mosquito strain (DIR 207)

Overview

The Gene Technology Regulator has received a licence application (DIR 207) from Oxitec Australia Pty Ltd for a commercial release of a genetically modified (GM) mosquito strain to help prevent dengue outbreaks.

Comments are now being sought on the consultation version of the Risk Assessment and Risk Management Plan (RARMP) that has been prepared by the Office of the Gene Technology Regulator (OGTR). 

Note: No personally identifying information will be released as part of your submission. Deidentified submissions summaries will be included in the finalised RARMP. Your personal information is protected by law, including the Privacy Act 1988 and the Australian Privacy Principles. More information about OGTR’s privacy policy can be found on our website.